These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 5287031)

  • 1. [Trial of treatment of chronic myeloid leukemias with mitomycin C].
    Olmer J; Gabriel B
    Presse Med (1893); 1971 Oct; 79(44):1965-7. PubMed ID: 5287031
    [No Abstract]   [Full Text] [Related]  

  • 2. Mitomycin C in the treatment of chronic myelogenous leukemia.
    Hoshino A
    Nagoya J Med Sci; 1967 Mar; 29(4):317-44. PubMed ID: 5234483
    [No Abstract]   [Full Text] [Related]  

  • 3. [Continual and periodic treatment of patients with chronic granulocytic leukemia].
    Colović M; Petrović M; Jancić MS; Banićević B; Vucić Lj; Janosević S; Ristić M
    Srp Arh Celok Lek; 1984 Apr; 112(4):487-93. PubMed ID: 6595809
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pregnancy during busulfan therapy of chronic granulocytic leukemia].
    Szentcsíki M; Brenner F; Balogh C; Hites L
    Orv Hetil; 1982 May; 123(21):1307-8. PubMed ID: 6955735
    [No Abstract]   [Full Text] [Related]  

  • 5. [Kinetic constants of leukocyte reduction in the course of treatment of chronic myeloleukosis with different doses of myelosan].
    Levitin EI; Kukharenko IuA; Evsenko LS; Emanuel' NM
    Izv Akad Nauk SSSR Biol; 1968; 5():739-43. PubMed ID: 5262634
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ambulatory treatment of patients with chronic myeloid leukemia].
    Lobanova NA
    Ter Arkh; 1981; 53(9):25-8. PubMed ID: 6946602
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the tactics of myelosan therapy of chronic myeloleukosis].
    Kassirskiĭ IA; Volkova MA
    Ter Arkh; 1967 Feb; 39(2):3-9. PubMed ID: 5252300
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination chemotherapy for chronic granulocytic leukaemia.
    Resegotti L; Dolci C
    Haematologica; 1981 Oct; 66(5):709-10. PubMed ID: 6796479
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chronic myeloid leukemia treated with busulfan. Clinical characteristics, prognostic factors, effect of treatment and survival in 82 cases].
    Larrain C; Cruz A; Codoceo V
    Rev Med Chil; 1984 Sep; 112(9):898-911. PubMed ID: 6598227
    [No Abstract]   [Full Text] [Related]  

  • 10. Chronic leukemias myelogenous.
    Weinrach RS
    Ariz Med; 1974 Oct; 31(10):750-2. PubMed ID: 4530709
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cytostatic treatment with the streptomyces extract mitomycin].
    Böhnel J; Stacher A
    Wien Med Wochenschr; 1968 Jan; 118(2):29-32. PubMed ID: 5243841
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro drug sensitivity studies of CFUc in chronic myelocytic leukemia: I. Suicide indices and busulfan sensitivity determinations during the chronic phase.
    Preisler HD; Kirshner J
    Exp Hematol; 1983 Aug; 11(7):618-25. PubMed ID: 6576910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Case of protracted course of myelocytic leukemia].
    Korytov SP
    Klin Med (Mosk); 1983 Mar; 61(3):102-3. PubMed ID: 6574289
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic myelocytic leukemia: treatment and biology.
    Preisler HD; Higby DJ
    N Y State J Med; 1982 Apr; 82(5):703-10. PubMed ID: 7043332
    [No Abstract]   [Full Text] [Related]  

  • 15. Hydroxyurea therapy in chronic myeloid leukemia.
    Agarwal MB; Mehta BC
    J Assoc Physicians India; 1982 Jul; 30(7):427-8. PubMed ID: 6963266
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapy of chronic myeloid leukemia].
    Mey U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(2):268-74. PubMed ID: 6168538
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytogenetic anomalies in a child born to a mother receiving busulfan for chronic myeloid leukaemia.
    Bhisey AN; Advani SH; Khare AG
    Indian J Cancer; 1982; 19(5):272-6. PubMed ID: 6219940
    [No Abstract]   [Full Text] [Related]  

  • 18. Continuous infusion idarubicin and oral busulfan as conditioning for patients with acute myeloid leukemia aged over 60 years undergoing autologous stem cell transplantation.
    Ferrara F; Palmieri S; Annunziata M; Viola A; Pocali B; Califano C; D'Arco AM; Mele G
    Bone Marrow Transplant; 2004 Oct; 34(7):573-6. PubMed ID: 15258559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term survival in chronic granulocytic leukemia].
    Coliţă A; Butoianu E; Nicoară S; Gociu M; Munteanu N; Hossu T; Ciocoiu A; Berceanu S
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(3):247-52. PubMed ID: 6140719
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of myeloid blastic crisis of chronic myelogenous leukemia.
    Preisler HD; Raza A; Higby D; Kirshner J; Woll J; Bennett J; Winton L; Weiner R; Richman C; Golomb H
    Cancer Treat Rep; 1984 Nov; 68(11):1351-5. PubMed ID: 6388833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.